Khan Sana, Rosner Mitchell H
Division of Nephrology, University of Virginia Health System, Charlottesville, VA, USA
Division of Nephrology, University of Virginia Health System, Charlottesville, VA, USA.
Perit Dial Int. 2018 Nov-Dec;38(6):397-401. doi: 10.3747/pdi.2018.00008.
End-stage renal disease patients with cirrhosis represent a therapeutic dilemma, with several difficulties associated with hemodialysis as a renal replacement therapy modality. Peritoneal dialysis is a feasible option for these patients, despite the confounders of associated infection risk, malnutrition, ascites management, and mechanical complications. This review covers the existing data on the outcomes and complications associated with the use of peritoneal dialysis in the cirrhotic patient.
患有肝硬化的终末期肾病患者面临治疗困境,作为肾脏替代治疗方式的血液透析存在诸多困难。尽管存在感染风险、营养不良、腹水管理及机械并发症等混杂因素,腹膜透析对这些患者而言仍是一种可行的选择。本综述涵盖了有关肝硬化患者使用腹膜透析的结局及并发症的现有数据。